Завершено
Фаза III
Trovax; Placebo; Standard of care therapy · Oxford BioMedica
Randomised,Double-blind,Placebo-controlled,Parallel Group Study TroVax, Added to First-line Standard of Care, Prolongs Survival of Patients With Locally Advanced or Metastatic Clear Cell Renal Adenocarcinoma.